Greenwich lifesciences inc

Author: kfuc

August undefined, 2024

WebApr 14, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director, Snehal Patel, recently bought US$62k worth of stock, for US$12.42 per share.Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a … Web1 day ago · Item 8.01 Other Events. Greenwich LifeSciences, Inc. is confirming the following in light of the interest in both of its GP2 Phase IIb clinical trial and Phase III clinical trial, Flamingo-01: The... April 13, 2024

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Jaye Thompson …

WebFind real-time GLSI - Greenwich Lifesciences Inc stock quotes, company profile, news and forecasts from CNN Business. chip romp

Jaye Thompson Purchases 1,000 Shares of Greenwich LifeSciences, Inc ...

WebApr 6, 2024 · Greenwich Lifesciences Inc ( GLSI) is around the top of the Biotechnology industry according to InvestorsObserver. GLSI received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. WebGreenwich LifeSciences, Inc. Daily – Vickers Top Insider Picks for 04/07/2024 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 … WebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 1-year low of $6.82 and a 1-year high of $21.50. The stock has a market cap of $153.81 million, a PE ratio of -21.00 and a beta of … chipron

GREENWICH LIFESCIENCES, INC. : Other Events (form 8-K)

Can Greenwich Lifesciences Inc (GLSI) Stock Rise to the Top of ...

WebGreenwich LifeSciences (Nasdaq: GLSI) is a public clinical-stage biopharmaceutical company focused on the development of an immunotherapy to prevent breast cancer … Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical … GP2 immunotherapy trains a patient’s T cells to recognize and destroy … The current, ongoing trial is a Phase III clinical trial registered with the name, … Company Profile. Business Description: Greenwich LifeSciences (the … about. management team; board of directors; technology. our gp2 cancer … Dr. Thompson has over 30 years of experience in pharmaceutical and … GP2 is a nine amino acid transmembrane peptide of the HER2/neu protein. … Understand cancer and immunotherapy, cancer’s escape from … Greenwich LifeSciences Provides Year End Update. Dec 1, 2024 6:00am EST. … Company Info - Greenwich LifeSciences, Inc. (GLSI) GP2 WebApr 14, 2024 · Greenwich LifeSciences has a 52-week low of $6.82 and a 52-week high of $21.50. The stock’s fifty day simple moving average is $14.92 and its 200-day simple moving average is $13.48. The... chi pro low emf dryerWebApr 14, 2024 · On Friday, March 10th, Snehal Patel bought 1,000 shares of Greenwich LifeSciences stock. The stock was bought at an average cost of $12.12 per share, with a total value of $12,120.00. chip rom bios

"WebApr 14, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director, Snehal Patel, … " - Greenwich lifesciences inc

Greenwich lifesciences inc

WebBy proceeding to use this website, you consent to our use of cookies as described in our Privacy Policy.. Close WebApr 6, 2024 · A high-level overview of Greenwich LifeSciences, Inc. (GLSI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Did you know?

WebDec 1, 2024 · STAFFORD, Texas, December 01, 2024 -- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of... WebSep 6, 2024 · Greenwich LifeSciences, Inc. is a one-man, one-asset shop. The asset, GP2, has produced excellent breast cancer data. Greenwich LifeSciences' CEO, Snehal Patel, runs this company almost all by ...

WebMar 13, 2024 · 12.48. USD. -1.34%. 04/10. HC Wainwright Cuts Greenwich LifeSciences' Price Target to $38 From $78, Keeps Buy Rating. MT. 03/31. GREENWICH LIFESCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) WebApr 14, 2024 · On Friday, March 10th, Snehal Patel bought 1,000 shares of Greenwich LifeSciences stock. The stock was bought at an average cost of $12.12 per share, with a …

WebMar 8, 2024 · Shares of Greenwich LifeSciences ( GLSI 0.80%) were skyrocketing 48.8% higher as of 3:19 p.m. EST on Monday. The huge jump came after the company announced the hiring of Jaye Thompson as vice... WebApr 10, 2024 · Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.

WebApr 14, 2024 · Investor & Public Relations Contact for Greenwich LifeSciences Dave Gentry RedChip Companies Inc. Office: 1-800-RED CHIP (733 2447) Cell: (407) 491-4498 [email protected] Release Summary

WebApr 10, 2024 · 31/03 Greenwich LifeSciences, Inc. annonce ses résultats pour l'exercice clos le 31 décembre ... grapevine campground gilaWebMar 3, 2024 · Investor & Public Relations Contact for Greenwich LifeSciences Dave Gentry RedChip Companies Inc. Office: 1-800-RED CHIP (733 2447) Cell: (407) 491-4498 Email: [email protected] Release Summary chip roofingWebApr 11, 2024 · NASDAQ:GLSI opened at $12.65 on Monday. Greenwich LifeSciences has a 52 week low of $6.82 and a 52 week high of $21.50. The stock’s fifty day moving average is $15.24 and its two-hundred day ... chi prompt care gig harborWebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 11th.The shares were bought at an average price of $11.87 per share, for a total transaction of $11,870.00. Following the completion of the transaction, the vice president now owns … grapevine campground in scWebApr 10, 2024 · Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following … chip rooneyWebApr 10, 2024 · A rating of 81 puts Greenwich Lifesciences Inc ( GLSI) near the top of the Healthcare sector according to InvestorsObserver . Greenwich Lifesciences Inc's score of 81 means that it ranks higher than 81% of stocks in the sector. In addition, its overall score of 57 ranks it higher than 57% of all stocks. GLSI has an Overall Score of 57. chip rom placa baseWebGreenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 8 hours 49 minutes Dow Futures +7.00 Nasdaq Futures -80.50( … grapevine campground ky